<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Acquired melanocytic nevi (moles)</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Acquired melanocytic nevi (moles)</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Acquired melanocytic nevi (moles)</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Raegan Hunt, MD, PhD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Julie V Schaffer, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jean L Bolognia, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Moise L Levy, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Robert P Dellavalle, MD, PhD, MSPH</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Hensin Tsao, MD, PhD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Rosamaria Corona, MD, DSc</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Sep 18, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Acquired melanocytic nevi are benign clonal proliferations of melanocytes that develop after birth. They can be classified as common (banal) or atypical and include several clinicopathologic variants, such as halo nevi, blue nevi, and Spitz nevi [<a href="#rid1">1</a>].</p><p>Acquired melanocytic nevi will be reviewed here. Congenital melanocytic nevi and specific types of acquired melanocytic nevi are reviewed separately. Other benign pigmented lesions are also reviewed separately.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/4847.html" rel="external">"Congenital melanocytic nevi"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/13519.html" rel="external">"Atypical (dysplastic) nevi"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/13523.html" rel="external">"Spitz nevus and atypical Spitz tumors"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/129132.html" rel="external">"BAP1-inactivated melanocytoma"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/5560.html" rel="external">"Benign pigmented skin lesions other than melanocytic nevi (moles)"</a>.)</p><p></p><p class="headingAnchor" id="H1188719981"><span class="h1">CELL OF ORIGIN AND CLASSIFICATION</span><span class="headingEndMark"> — </span>Melanocytic nevi are benign clonal proliferations of a type of melanocyte known as a "nevus cell." Both melanocytes and nevus cells can produce the pigment melanin. There are two major differences between ordinary melanocytes that reside in the basal layer of the epidermis and nevus cells:</p><p class="bulletIndent1"><span class="glyph">●</span>Nevus cells lack dendritic processes, except for those within blue nevi, and appear as oval or spindle cells.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Nevus cells cluster as nests within the lower epidermis and/or dermis, whereas epidermal melanocytes are evenly dispersed as single units.</p><p></p><p>Based on the location of the melanocyte nests  (<a class="graphic graphic_figure graphicRef65457" href="/d/graphic/65457.html" rel="external">figure 1</a>), nevi are classified into:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Junctional nevi</strong> – The nests of melanocytes are at the dermal-epidermal junction.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Compound nevi</strong> – The nests of melanocytes are at the dermal-epidermal junction and in the dermis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Intradermal nevi</strong> – The nests of melanocytes are in the dermis. With progressive migration of melanocytes from the dermal-epidermal junction into the dermis, these nevi become more elevated and less pigmented over time.</p><p></p><p class="headingAnchor" id="H4"><span class="h1">PREDISPOSING FACTORS</span><span class="headingEndMark"> — </span>Factors related to the development of nevi (with the exception of blue nevi and perhaps Spitz nevi) include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Genetic factors</strong> – There is a familial tendency to have a large number of moles. Germline<em> </em>polymorphisms that impact the number, morphology (eg, common versus atypical), and dermoscopic features (eg, globular versus reticular pattern) of nevi have been identified in several genes, including cyclin-dependent kinase inhibitor <em>p16/CDKN2A</em> and cyclin-dependent kinase <em>CDK4</em>, interferon regulatory factor 4 (<em>IRF4</em>), telomerase reverse transcriptase (<em>TERT</em>), and protection of telomeres 1 (<em>POT1</em>) [<a href="#rid2">2,3</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sun exposure</strong> – The degree of sun exposure during childhood, especially when intense and intermittent, impacts nevus development [<a href="#rid4">4-10</a>]. Although the results of studies evaluating the effects of sunscreen use on the development of nevi are inconsistent, in one randomized controlled study, school-aged children who were supplied with and instructed to use a broad-spectrum sunscreen developed significantly fewer new nevi over a three-year period than controls [<a href="#rid11">11,12</a>]. Secondary environmental factors that influence the development and growth of acquired melanocytic nevi include blistering disorders, lichen sclerosus, chemotherapy, systemic immunosuppression, and endocrine conditions [<a href="#rid13">13</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cutaneous phenotype</strong> – Higher nevus counts are seen in individuals with lightly pigmented skin [<a href="#rid5">5,9,14-16</a>]. The mean number of nevi in White adolescents is approximately 15 to 80, compared with five or fewer in Black, Asian, or Native American adolescents [<a href="#rid10">10,14,16</a>]. However, individuals with very lightly pigmented skin, especially when accompanied by red hair, also tend to have fewer nevi, but they usually have numerous solar lentigines and freckles [<a href="#rid17">17,18</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Immunosuppression</strong> – Increased nevus counts have been reported in patients taking conventional immunosuppressants as well as biologics over weeks to months after initiating treatment [<a href="#rid19">19,20</a>].</p><p></p><p class="headingAnchor" id="H5"><span class="h1">PRINCIPLES OF DIAGNOSIS AND INDICATIONS FOR BIOPSY</span><span class="headingEndMark"> — </span>The diagnosis of a nevus is typically based upon the clinical and dermoscopic appearance. Clinicians should be able to recognize the different types of nevi and atypical features that raise suspicion of melanoma, such as diameter &gt;6 mm, irregular borders, asymmetry, variable pigmentation, and change in appearance over time. The last is especially important in adults, as clinical changes (eg, enlargement, increased elevation) and consistent dermoscopic changes occur as part of the normal natural history of nevi in children and adolescents [<a href="#rid21">21</a>]. (See <a class="local">'Natural history'</a> below.)</p><p>Patients with nevi showing atypical features should be referred to a dermatologist for further examination and diagnosis. (See  <a class="medical medical_review" href="/d/html/15806.html" rel="external">"Melanoma: Clinical features and diagnosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Indications for biopsy</strong> – We do <strong>not</strong> suggest removal of nevi simply to confirm or rule out the presence of architectural disorder histologically. Recognizing the natural history and clinical spectrum of nevi in pediatric patients as well as potentially worrisome findings in this age group can help to avoid unnecessary procedures. Potential indications for biopsy of acquired melanocytic nevi include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Nevi on the palms or soles with mottled pigmentation, pigment on the ridges (as opposed to furrows) of skin markings on dermoscopy  (<a class="graphic graphic_picture graphicRef89397" href="/d/graphic/89397.html" rel="external">picture 1</a>), and &gt;6 mm in diameter. (See  <a class="medical medical_review" href="/d/html/4843.html" rel="external">"Pathologic characteristics of melanoma", section on 'Acral lentiginous melanoma'</a> and  <a class="medical medical_review" href="/d/html/16551.html" rel="external">"Dermoscopy of pigmented lesions of the palms and soles"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Nevi originating in the nail matrix that present as single bands of dark color or are ≥3 mm wide; the threshold for biopsy is considerably lower in adults than in children. (See  <a class="medical medical_review" href="/d/html/121519.html" rel="external">"Longitudinal melanonychia", section on 'When to biopsy'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Nevi with marked asymmetry (based on irregular outline and/or color variation), areas of regression (oftentimes gray-blue or white in color), development of areas of pink or red color, or a history of rapid change or symptoms. (See  <a class="medical medical_review" href="/d/html/15806.html" rel="external">"Melanoma: Clinical features and diagnosis", section on 'Introduction'</a> and  <a class="medical medical_review" href="/d/html/15806.html" rel="external">"Melanoma: Clinical features and diagnosis", section on 'Management of suspicious lesions'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>An atypical nevus that has different clinical characteristics as compared with the remainder of the nevi in a given patient (ie, the "ugly duckling"). (See  <a class="medical medical_review" href="/d/html/13519.html" rel="external">"Atypical (dysplastic) nevi", section on 'The 'signature nevus' and the 'ugly duckling' sign'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A halo nevus in which the central nevus has atypical or worrisome features. (See <a class="local">'Halo nevi'</a> below.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A cellular blue nevus that has developed a superimposed change (eg, a papulonodule). (See <a class="local">'Blue nevi'</a> below.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A Spitz nevus with atypical clinical features (eg, diameter &gt;1 cm, asymmetry, or ulceration). (See <a class="local">'Spitz nevi'</a> below and  <a class="medical medical_review" href="/d/html/13523.html" rel="external">"Spitz nevus and atypical Spitz tumors"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Biopsy technique</strong> – If a decision to biopsy is made for lesions suspicious for melanoma, the preferred biopsy technique is one that allows histologic examination of the entire lesion. It is important to give the dermatopathologist information (eg, presence of foci of eccentric hyperpigmentation) about any pigmented lesion that has been biopsied. (See  <a class="medical medical_review" href="/d/html/5577.html" rel="external">"Skin biopsy techniques"</a>.)</p><p></p><p class="headingAnchor" id="H6"><span class="h1">COMMON ACQUIRED MELANOCYTIC NEVI</span></p><p class="headingAnchor" id="H7"><span class="h2">Clinical features</span><span class="headingEndMark"> — </span>Common nevi first appear during childhood, increase in number during adolescence and early adulthood, and then decrease with age. (See <a class="local">'Natural history'</a> below.)</p><p>They appear as brown macules that may become raised over time and tend to be small (≤6 mm in diameter) and symmetric with a homogeneous surface, even pigmentation, round or oval shape, regular outline, and a sharply demarcated border  (<a class="graphic graphic_picture graphicRef73384" href="/d/graphic/73384.html" rel="external">picture 2</a>). Close inspection sometimes reveals pigmentary stippling or perifollicular hypopigmentation.</p><p>Nevi are often concentrated in sun-exposed areas of the trunk or, particularly in females, on the lower extremities [<a href="#rid22">22</a>]. Less commonly, they occur in acral sites, such as the palms, soles, and nail matrix. (See <a class="local">'Nevi on palms/soles'</a> below and <a class="local">'Nevi originating from the nail matrix'</a> below.)</p><p>As many as one-third of children and adolescents have acquired nevi on the scalp; nevi in this location may be a marker for the development of a greater total number of nevi [<a href="#rid23">23</a>].</p><p class="headingAnchor" id="H691426228"><span class="h2">Dermoscopic features</span><span class="headingEndMark"> — </span>Dermoscopic examination of acquired melanocytic nevi in children most often reveals a globular pattern  (<a class="graphic graphic_picture graphicRef67691" href="/d/graphic/67691.html" rel="external">picture 3</a>), especially in lesions located on the head, neck, or upper trunk. In contrast, a reticular pattern is more common in acquired nevi located on the extremities and in children with more darkly pigmented skin, as well as in nevi that develop during adulthood  (<a class="graphic graphic_picture graphicRef57412" href="/d/graphic/57412.html" rel="external">picture 4</a>) [<a href="#rid24">24</a>]. (See  <a class="medical medical_review" href="/d/html/13522.html" rel="external">"Dermoscopic evaluation of skin lesions"</a> and  <a class="medical medical_review" href="/d/html/16551.html" rel="external">"Dermoscopy of pigmented lesions of the palms and soles"</a>.)</p><p>The globular pattern is histologically associated with a prominent dermal component with or without large junctional nests, while the reticular pattern corresponds to a prominent junctional component with lentiginous melanocytic hyperplasia with or without small junctional nests.</p><p class="headingAnchor" id="H4155778923"><span class="h2">Genetics</span><span class="headingEndMark"> — </span>Most common acquired melanocytic nevi harbor somatic <em>BRAF</em> V600E driver mutations with high frequency, while a minority have <em>NRAS</em> mutations [<a href="#rid25">25-28</a>]. Acquired nevi with a dermoscopic globular pattern, which histologically corresponds to a prominent dermal component with or without junctional nests, are more likely to have an underlying somatic <em>BRAF</em> V600E<sup> </sup>activating mutation than those with a reticular pattern (approximately 90 versus 30 percent) [<a href="#rid29">29</a>].</p><p>Nevi located in sun-exposed areas are more likely to have ultraviolet (UV) signature mutations (eg, C&gt;T transitions) compared with nevi in shielded body sites, suggesting a contributing pathogenetic role of UV exposure [<a href="#rid30">30,31</a>]. Other genetic alterations found in acquired melanocytic nevi include defective deoxyribonucleic acid (DNA) mismatch repair mutations and copy number aberrations (eg, loss of heterozygosity) [<a href="#rid26">26</a>].</p><p class="headingAnchor" id="H2160245993"><span class="h2">Natural history</span><span class="headingEndMark"> — </span>Common acquired melanocytic nevi begin to appear after the first six months of life, increase in number during childhood and adolescence, reach a peak count in the third decade, and then slowly regress with age [<a href="#rid14">14,32</a>]. However, new nevi may also develop in adult individuals [<a href="#rid33">33</a>].</p><p>Substantial nevus turnover occurs during the first two decades of life. For example, over a three- to four-year period in early adolescence, the net number of nevi increases by a mean of 40 to 60 percent, and approximately 15 percent of nevi disappear [<a href="#rid32">32,34</a>]. Although a changing nevus may raise concern for melanoma in an adult, enlargement and increased elevation occur as part of the normal natural history of nevi in children and adolescents [<a href="#rid21">21</a>].</p><p>The clinical and histologic evolution of individual lesions from junctional to compound to dermal nevi  (<a class="graphic graphic_figure graphicRef65457" href="/d/graphic/65457.html" rel="external">figure 1</a>) can correspond to this cycle:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Junctional nevi</strong> – Junctional nevi are macular or minimally raised, have preserved skin markings, and range from brown to black in color, sometimes with darker pigmentation in the center than at the edge  (<a class="graphic graphic_picture graphicRef57022" href="/d/graphic/57022.html" rel="external">picture 5</a>). They can be similar in appearance to simple lentigines. (See  <a class="medical medical_review" href="/d/html/5560.html" rel="external">"Benign pigmented skin lesions other than melanocytic nevi (moles)", section on 'Simple lentigo'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Compound nevi</strong> – Compound nevi are classically pigmented papules, but in some lesions, the degree of elevation is subtle. Their surface can be smooth and dome shaped or papillomatous, and they vary in color from tan to dark brown  (<a class="graphic graphic_picture graphicRef81931" href="/d/graphic/81931.html" rel="external">picture 6</a>). The more symmetric and uniform in color a compound nevus is, especially when tan to medium brown in color, the less one needs to worry about the lesion.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Intradermal nevi</strong> – Nevus cells residing in the dermis often stop producing melanin. As a result, intradermal nevi are usually skin-colored to tan papules that are dome shaped, papillomatous, or pedunculated with a soft, rubbery texture  (<a class="graphic graphic_picture graphicRef76961" href="/d/graphic/76961.html" rel="external">picture 7</a>). Occasionally, they have speckles of brown pigmentation, terminal hairs, or pseudohorn cysts (ie, accumulations of keratin within invaginations of hyperplastic epidermis). Pseudohorn cysts occur more frequently in seborrheic keratoses, which typically develop in adults, than in intradermal nevi. (See  <a class="medical medical_review" href="/d/html/5573.html" rel="external">"Overview of benign lesions of the skin", section on 'Seborrheic keratosis'</a>.)</p><p></p><p class="headingAnchor" id="H10"><span class="h2">Management</span><span class="headingEndMark"> — </span>Most acquired nevi remain benign throughout the lifetime of a person and require no treatment other than longitudinal observation. Because a large number of acquired nevi are a recognized risk factor for melanoma, patients with multiple acquired nevi should be followed with periodic total body skin examinations and counseled regarding sun protection [<a href="#rid35">35</a>]. (See  <a class="medical medical_review" href="/d/html/4844.html" rel="external">"Melanoma: Epidemiology and risk factors", section on 'Common (typical) nevi'</a> and  <a class="medical medical_review" href="/d/html/4842.html" rel="external">"Primary prevention of melanoma"</a> and  <a class="medical medical_review" href="/d/html/15806.html" rel="external">"Melanoma: Clinical features and diagnosis"</a>.)</p><p>There is no benefit to "prophylactic" removal of nevi, as more than one-half of cutaneous melanomas arise de novo (ie, not in association with a nevus). Nevertheless, when melanocytic nevi are removed, no matter what the reason, the specimens should always be sent for histologic examination.</p><p class="headingAnchor" id="H3223841708"><span class="h1">NEVI OF SPECIAL SITES</span></p><p class="headingAnchor" id="H1055427378"><span class="h2">Scalp nevi</span><span class="headingEndMark"> — </span>Acquired scalp nevi are a subset of melanocytic nevi seen more frequently in children and young adults. A scalp nevus can present as a common nevus (flat or raised, symmetric lesion with a smooth surface), as a papillomatous nevus, as a blue nevus, or may show atypical features (eg, asymmetry, irregular border, multiple colors, diameter &gt;6 mm) that raise concern for melanoma [<a href="#rid36">36</a>].</p><p>The "eclipse" nevus is a type of compound nevus that often develops on the scalp of children and is characterized by a tan center and brown, oftentimes stellate rim  (<a class="graphic graphic_picture graphicRef73770 graphicRef53622" href="/d/graphic/73770.html" rel="external">picture 8A-B</a>). Despite their two colors and irregular borders, eclipse nevi have benign behavior and, in the absence of a superimposed concerning feature, do not need to be biopsied or excised [<a href="#rid37">37</a>]. A variation on this, known as the "cockade" nevus, which has a pigmented center surrounded by a hypopigmented ring inside an outer pigmented border without concerning symptoms or features, also does not need to be biopsied or excised in children or adolescents [<a href="#rid37">37</a>].</p><p class="headingAnchor" id="H3378188963"><span class="h2">Nevi on palms/soles</span><span class="headingEndMark"> — </span>Nevi on the palms and soles (acral melanocytic nevi) occur in individuals of all ethnic backgrounds but are more common in those with darkly pigmented skin or numerous melanocytic nevi [<a href="#rid38">38-41</a>]. Nevi located on the palms and soles are usually of the junctional or compound type and are typically brown to dark brown in color.</p><p>On dermoscopy, they often show linear streaks of darker pigmentation in the furrows of skin markings, the so-called parallel furrow pattern  (<a class="graphic graphic_picture graphicRef89403" href="/d/graphic/89403.html" rel="external">picture 9</a>), or a regular fibrillar pattern  (<a class="graphic graphic_picture graphicRef89451" href="/d/graphic/89451.html" rel="external">picture 10</a>). (See  <a class="medical medical_review" href="/d/html/16551.html" rel="external">"Dermoscopy of pigmented lesions of the palms and soles"</a>.)</p><p>Referral to a dermatologist is generally warranted when acquired acral nevi have marked asymmetry, mottled pigmentation, or a large size (&gt;6 mm). (See  <a class="medical medical_review" href="/d/html/4843.html" rel="external">"Pathologic characteristics of melanoma", section on 'Acral lentiginous melanoma'</a>.)</p><p class="headingAnchor" id="H1020672659"><span class="h2">Nevi originating from the nail matrix</span><span class="headingEndMark"> — </span>Acral nevi or lentigines that involve the nail matrix can present as longitudinal melanonychia, a tan, brown, or black streak caused by increased melanin deposition in the nail plate  (<a class="graphic graphic_picture graphicRef142601" href="/d/graphic/142601.html" rel="external">picture 11</a>). In individuals with darkly pigmented skin, longitudinal melanonychia is commonly seen in multiple nails due to increased melanin production by normal nail matrix melanocytes  (<a class="graphic graphic_picture graphicRef64603" href="/d/graphic/64603.html" rel="external">picture 12</a>). Streaks that develop in childhood are usually benign [<a href="#rid42">42</a>]. However, single bands that are dark/irregular in color or wide (≥4 mm), become darker or wider with time, are associated with nail dystrophy, or have extension of pigmentation onto the nail fold or surrounding skin may warrant biopsy of the nail matrix to exclude melanoma [<a href="#rid43">43</a>]. (See  <a class="medical medical_review" href="/d/html/121519.html" rel="external">"Longitudinal melanonychia"</a>.)</p><p class="headingAnchor" id="H11"><span class="h1">ATYPICAL NEVI</span><span class="headingEndMark"> — </span>Atypical nevi are benign acquired melanocytic nevi clinically characterized by a diameter &gt;5 mm; asymmetry (one-half of the lesion does not match the other in terms of shape or color); irregular or ill-defined borders; and variegated color, with areas of pink, tan, brown, or dark brown  (<a class="graphic graphic_picture graphicRef78891 graphicRef70320 graphicRef80725 graphicRef68734" href="/d/graphic/78891.html" rel="external">picture 13A-D</a>) [<a href="#rid44">44</a>]. The clinical significance of atypical nevi lies in their association with an increased risk of melanoma. (See  <a class="medical medical_review" href="/d/html/13519.html" rel="external">"Atypical (dysplastic) nevi", section on 'Clinical significance'</a>.)</p><p>Atypical nevi are also commonly referred to as "dysplastic nevi," although this term should be reserved for <strong>histologically</strong> dysplastic lesions, which according to the World Health Organization (WHO) 2018 classification of skin tumors are lesions that show irregular nests of intraepidermal melanocytes and increased density of non-nested junctional melanocytes with cytologically atypical melanocytes rated as having low- or high-grade dysplasia [<a href="#rid44">44,45</a>].</p><p>The clinical and dermoscopic features, diagnosis, differential diagnosis, and management of atypical nevi are discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/13519.html" rel="external">"Atypical (dysplastic) nevi"</a>.)</p><p class="headingAnchor" id="H18"><span class="h1">HALO NEVI</span></p><p class="headingAnchor" id="H19"><span class="h2">Clinical features</span><span class="headingEndMark"> — </span>The halo nevus (Sutton's nevus) is a melanocytic nevus surrounded by a round or oval, usually symmetric, halo of depigmentation. This pigment loss often heralds the spontaneous regression of the central nevus via a process thought to involve a T cell-mediated immune response to nevus antigens [<a href="#rid46">46</a>]. The halo phenomenon typically involves common acquired melanocytic nevi but may also be seen with congenital melanocytic nevi, blue nevi, Spitz nevi, and melanoma.</p><p>Halo nevi are relatively common in children and young adults and have a higher incidence in patients with an increased number of nevi and/or a personal or family history of vitiligo. The back is the most common location for halo nevi, and multiple lesions are present in approximately one-half of cases [<a href="#rid47">47,48</a>].</p><p>Halo nevi are rare in middle-aged and older adults; in the latter population, the possibility of the halo nevi representing an immune reaction to a cutaneous melanoma must be considered.</p><p class="headingAnchor" id="H2025356030"><span class="h2">Dermoscopic features</span><span class="headingEndMark"> — </span>Globular and homogeneous patterns, or a combination of the two, are typical dermoscopic features of halo nevi, with a minority exhibiting a reticular pattern [<a href="#rid49">49</a>].</p><p class="headingAnchor" id="H2992275819"><span class="h2">Natural history</span><span class="headingEndMark"> — </span>Over months or even years, halo nevi undergo progressive involution through four recognized clinical stages, ending with total regression of the central nevus [<a href="#rid50">50</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Stage I – Pigmented nevus surrounded by a halo of depigmentation  (<a class="graphic graphic_picture graphicRef65988" href="/d/graphic/65988.html" rel="external">picture 14</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Stage II – Pink nevus surrounded by a halo of depigmentation  (<a class="graphic graphic_picture graphicRef57744" href="/d/graphic/57744.html" rel="external">picture 15</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Stage III – Circular area of depigmentation, with disappearance of the nevus</p><p class="bulletIndent1"><span class="glyph">●</span>Stage IV – Normal-appearing skin after repigmentation of the halo</p><p></p><p>In some cases, the central nevus may darken rather than lighten, developing hyperpigmentation in a reticular pattern [<a href="#rid51">51</a>]. Hyperkeratotic surface change of the benign central nevus has been reported to occur in some children prior to halo development and also concomitantly with the halo phenomenon [<a href="#rid52">52,53</a>].</p><p class="headingAnchor" id="H1583402383"><span class="h2">Association with melanoma</span><span class="headingEndMark"> — </span>In adults, halo nevi may rarely represent an immune reaction to a cutaneous melanoma. In a multicenter study that included 879 patients with 888 halo nevi diagnosed at a mean age of 36 years, melanoma occurred in 95 patients [<a href="#rid54">54</a>]. The risk of developing a melanoma in the year after halo nevus diagnosis was 1 percent, similar to that of patients with atypical nevi or a personal or family history of melanoma.</p><p class="headingAnchor" id="H20"><span class="h2">Management</span><span class="headingEndMark"> — </span>It is important to assess the clinical and dermoscopic features of the central nevus. A biopsy is not indicated if the central nevus is banal in appearance and dermoscopy shows a typical benign pattern [<a href="#rid55">55</a>]. Because children with halo nevi often have an increased number of nevi in general, a total body skin examination should be performed. Referral to a dermatologist may be warranted. (See <a class="local">'Common acquired melanocytic nevi'</a> above.)</p><p>If there are atypical or worrisome features suspicious for melanoma, then a biopsy of the central nevus should be performed. However, there is no reason to excise the halo.</p><p class="headingAnchor" id="H21"><span class="h1">BLUE NEVI</span></p><p class="headingAnchor" id="H22"><span class="h2">Clinical features</span><span class="headingEndMark"> — </span>Blue nevi are benign proliferations of dendritic dermal melanocytes that actively produce melanin. The blue color (ceruloderma) is due to the preferential scattering of shorter wavelengths of light by the dermal melanin, a phenomenon known as the Tyndall effect. The sites of predilection of blue nevi (eg, the head and neck, dorsal aspect of the distal extremities, and sacral area) represent locations where active dermal melanocytes are normally still present at the time of birth. (See  <a class="medical medical_review" href="/d/html/5560.html" rel="external">"Benign pigmented skin lesions other than melanocytic nevi (moles)", section on 'Dermal melanocytoses'</a>.)</p><p>Several variants of blue nevi have been described [<a href="#rid56">56</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Common blue nevus</strong> – The common blue nevus typically presents as a solitary, uniformly blue to blue-black, dome-shaped papule with preserved skin markings that measures &lt;1 cm in diameter. These nevi often arise in adolescence and are most often found on the dorsal surface of the hands and feet  (<a class="graphic graphic_picture graphicRef95262" href="/d/graphic/95262.html" rel="external">picture 16</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cellular blue nevus</strong> – The cellular blue nevus tends to be a larger and more elevated nodule or plaque, measuring at least 1 cm in diameter, with a smooth or slightly irregular surface. Cellular blue nevi may be congenital or acquired and are most often located on the scalp, buttocks, sacrum, or face.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A hypopigmented variant of blue nevus that lacks the characteristic blue color is occasionally observed.</p><p></p><p>Multiple blue nevi may be a clinical feature of Carney complex, a rare multiple neoplasia syndrome  (<a class="graphic graphic_table graphicRef66428" href="/d/graphic/66428.html" rel="external">table 1</a>) [<a href="#rid57">57</a>]. (See  <a class="medical medical_review" href="/d/html/100662.html" rel="external">"Carney complex"</a>.)</p><p class="headingAnchor" id="H2435398986"><span class="h2">Dermoscopic features</span><span class="headingEndMark"> — </span>On dermoscopy, blue nevi typically appear as homogeneous blue, blue-gray, blue-brown, or blue-black structureless lesions  (<a class="graphic graphic_picture graphicRef96284" href="/d/graphic/96284.html" rel="external">picture 17</a>).</p><p class="headingAnchor" id="H1278298950"><span class="h2">Genetics</span><span class="headingEndMark"> — </span>Blue nevi have distinctive genetic alterations compared with common nevi. Most blue nevi have a somatic activating mutation in the <em>GNAQ </em>or <em>GNA11 </em>genes, which encode G-protein alpha-subunits [<a href="#rid58">58</a>]. Occasionally, mutations in <em>KRAS</em>, <em>CYSLTR2</em>,<em> </em>and<em> PLCB4</em> are also seen [<a href="#rid59">59-61</a>].</p><p class="headingAnchor" id="H23"><span class="h2">Differential diagnosis</span><span class="headingEndMark"> — </span>The most common entities in the clinical differential diagnosis of a blue nevus include [<a href="#rid62">62-65</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Traumatic tattoo</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pencil-core granuloma (also called graphite foreign body granuloma) from dermal implantation of graphite from a pencil</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Nodular melanoma</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Dermal metastases of melanoma</p><p></p><p class="headingAnchor" id="H24"><span class="h2">Management</span><span class="headingEndMark"> — </span>Small, stable blue nevi require no intervention. However, blue lesions appearing suddenly or undergoing clinical change should be biopsied. Because there are reports of melanoma arising within cellular blue nevi (particularly those located on the scalp), patients with congenital cellular blue nevi that are difficult to monitor due to location (eg, difficult for the patient to monitor on their buttock or difficult to examine on scalp due to hair density) should be referred to a dermatologist for discussion of possible surgical excision [<a href="#rid65">65-67</a>]. (See <a class="local">'Principles of diagnosis and indications for biopsy'</a> above.)</p><p class="headingAnchor" id="H25"><span class="h1">SPITZ NEVI</span><span class="headingEndMark"> — </span>Spitz nevi (spindle and epithelioid cell nevi) are benign, usually acquired proliferations of melanocytes with histopathologic features that sometimes overlap with those of melanoma. Spitz nevi often develop during childhood, and they are most commonly located on the face and lower extremities. Lesions tend to exhibit a rapid initial growth phase that can be alarming to patients and their parents/caregivers.</p><p>Spitz nevi classically appear as uniformly pink, tan, red or red-brown, dome-shaped papules or nodules  (<a class="graphic graphic_picture graphicRef56097 graphicRef85817" href="/d/graphic/56097.html" rel="external">picture 18A-B</a>). They are usually symmetric, well circumscribed, and &lt;1 cm in diameter. Darkly pigmented lesions are occasionally seen, typically exhibiting a symmetric "starburst" dermoscopic pattern with peripheral streaks  (<a class="graphic graphic_picture graphicRef55874" href="/d/graphic/55874.html" rel="external">picture 19</a>). The pigmented spindle cell nevus of Reed, a variant of the Spitz nevus, characteristically presents in adolescents or young adults as a dark brown to black, thin papule on the thigh  (<a class="graphic graphic_picture graphicRef68392" href="/d/graphic/68392.html" rel="external">picture 20</a>) [<a href="#rid68">68</a>].</p><p>The pathogenesis, clinical presentation, diagnosis, and management of Spitz nevi are discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/13523.html" rel="external">"Spitz nevus and atypical Spitz tumors"</a> and  <a class="medical medical_review" href="/d/html/129823.html" rel="external">"Spitz nevus/tumor in children: Diagnosis and management"</a>.)</p><p class="headingAnchor" id="H2844347031"><span class="h1">BAP1-INACTIVATED MELANOCYTOMAS</span><span class="headingEndMark"> — </span>Germline mutations in the <em>BAP1</em> gene lead to a rare autosomal dominant tumor predisposition syndrome that features atypical melanocytic neoplasms  (<a class="graphic graphic_picture graphicRef131185 graphicRef131177" href="/d/graphic/131185.html" rel="external">picture 21A-B</a>) and an increased risk of uveal as well as cutaneous melanoma and other tumors, including mesothelioma and renal cell carcinoma [<a href="#rid69">69</a>]. (See  <a class="medical medical_review" href="/d/html/129132.html" rel="external">"BAP1-inactivated melanocytoma"</a>.)</p><p class="headingAnchor" id="H33"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definition </strong>– Acquired melanocytic nevi are benign proliferations of a type of melanocyte known as a "nevus cell." They include common nevi; atypical nevi; and several additional variants, including halo nevi, blue nevi, and Spitz nevi. (See <a class="local">'Cell of origin and classification'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Common nevi</strong> – Common (banal) acquired melanocytic nevi tend to be ≤6 mm in diameter and symmetric with a homogeneous surface, even pigmentation, round or oval shape, regular outline, and a sharply demarcated border  (<a class="graphic graphic_picture graphicRef73384" href="/d/graphic/73384.html" rel="external">picture 2</a>). (See <a class="local">'Common acquired melanocytic nevi'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Atypical nevi</strong> – Atypical nevi are benign acquired melanocytic nevi that share some of the clinical features of melanoma (ie, asymmetry, border irregularities  (<a class="graphic graphic_picture graphicRef68734" href="/d/graphic/68734.html" rel="external">picture 13D</a> and <a class="graphic graphic_picture graphicRef70320" href="/d/graphic/70320.html" rel="external">picture 13B</a>), color variability, and diameter &gt;6 mm  (<a class="graphic graphic_picture graphicRef80725" href="/d/graphic/80725.html" rel="external">picture 13C</a>)). (See  <a class="medical medical_review" href="/d/html/13519.html" rel="external">"Atypical (dysplastic) nevi"</a>.)</p><p></p><p class="bulletIndent1">Multiple atypical nevi are a phenotypic marker of increased risk of melanoma. The risk of melanoma also depends upon the total number of nevi, family and/or personal history of melanoma, and sun exposure history. (See  <a class="medical medical_review" href="/d/html/4844.html" rel="external">"Melanoma: Epidemiology and risk factors"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Halo nevi</strong> – Halo nevi are melanocytic nevi surrounded by a round or oval halo of depigmentation  (<a class="graphic graphic_picture graphicRef65988" href="/d/graphic/65988.html" rel="external">picture 14</a>). The halo phenomenon usually involves common acquired melanocytic nevi but may also be seen with congenital nevi, blue nevi, Spitz nevi, and melanoma. (See <a class="local">'Halo nevi'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Blue nevi</strong> – Blue nevi are benign proliferations of dendritic dermal melanocytes that actively produce melanin. They typically occur on the head and neck, dorsal aspect of the distal extremities, and sacral area. Multiple blue nevi may indicate a syndrome such as the Carney complex  (<a class="graphic graphic_table graphicRef66428" href="/d/graphic/66428.html" rel="external">table 1</a>). (See <a class="local">'Blue nevi'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Spitz nevi</strong> – Spitz nevi are uniformly pink, tan, red or red-brown, dome-shaped, hairless papules or nodules. They are usually symmetric, well circumscribed, and &lt;1 cm in diameter  (<a class="graphic graphic_picture graphicRef56097" href="/d/graphic/56097.html" rel="external">picture 18A</a>). (See <a class="local">'Spitz nevi'</a> above and  <a class="medical medical_review" href="/d/html/13523.html" rel="external">"Spitz nevus and atypical Spitz tumors"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Indication for biopsy</strong> – We do <strong>not</strong> remove nevi simply to confirm or rule out the presence of architectural disorder histologically. However, a biopsy is indicated for lesions with features suspicious for melanoma. (See <a class="local">'Principles of diagnosis and indications for biopsy'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Frischhut N, Zelger B, Andre F, Zelger BG. The spectrum of melanocytic nevi and their clinical implications. J Dtsch Dermatol Ges 2022; 20:483.</a></li><li><a class="nounderline abstract_t">Orlow I, Satagopan JM, Berwick M, et al. Genetic factors associated with naevus count and dermoscopic patterns: preliminary results from the Study of Nevi in Children (SONIC). Br J Dermatol 2015; 172:1081.</a></li><li><a class="nounderline abstract_t">Juan HY, Zhou AE, Hoegler KM, Khachemoune A. Overview of familial syndromes with increased skin malignancies. Arch Dermatol Res 2023; 315:707.</a></li><li><a class="nounderline abstract_t">Dulon M, Weichenthal M, Blettner M, et al. Sun exposure and number of nevi in 5- to 6-year-old European children. J Clin Epidemiol 2002; 55:1075.</a></li><li><a class="nounderline abstract_t">Wiecker TS, Luther H, Buettner P, et al. Moderate sun exposure and nevus counts in parents are associated with development of melanocytic nevi in childhood: a risk factor study in 1,812 kindergarten children. Cancer 2003; 97:628.</a></li><li><a class="nounderline abstract_t">Harrison SL, MacLennan R, Buettner PG. Sun exposure and the incidence of melanocytic nevi in young Australian children. Cancer Epidemiol Biomarkers Prev 2008; 17:2318.</a></li><li><a class="nounderline abstract_t">Oliveria SA, Satagopan JM, Geller AC, et al. Study of Nevi in Children (SONIC): baseline findings and predictors of nevus count. Am J Epidemiol 2009; 169:41.</a></li><li><a class="nounderline abstract_t">Aalborg J, Morelli JG, Mokrohisky ST, et al. Tanning and increased nevus development in very-light-skinned children without red hair. Arch Dermatol 2009; 145:989.</a></li><li><a class="nounderline abstract_t">De Giorgi V, Gori A, Greco A, et al. Sun-Protection Behavior, Pubertal Development and Menarche: Factors Influencing the Melanocytic Nevi Development-The Results of an Observational Study of 1,512 Children. J Invest Dermatol 2018; 138:2144.</a></li><li><a class="nounderline abstract_t">Asdigian NL, Barón AE, Morelli JG, et al. Trajectories of Nevus Development From Age 3 to 16 Years in the Colorado Kids Sun Care Program Cohort. JAMA Dermatol 2018; 154:1272.</a></li><li><a class="nounderline abstract_t">Gallagher RP, Rivers JK, Lee TK, et al. Broad-spectrum sunscreen use and the development of new nevi in white children: A randomized controlled trial. JAMA 2000; 283:2955.</a></li><li><a class="nounderline abstract_t">Autier P, Doré JF, Cattaruzza MS, et al. Sunscreen use, wearing clothes, and number of nevi in 6- to 7-year-old European children. European Organization for Research and Treatment of Cancer Melanoma Cooperative Group. J Natl Cancer Inst 1998; 90:1873.</a></li><li><a class="nounderline abstract_t">Schaffer JV. Pigmented lesions in children: when to worry. Curr Opin Pediatr 2007; 19:430.</a></li><li><a class="nounderline abstract_t">Luther H, Altmeyer P, Garbe C, et al. Increase of melanocytic nevus counts in children during 5 years of follow-up and analysis of associated factors. Arch Dermatol 1996; 132:1473.</a></li><li><a class="nounderline abstract_t">Garbe C, Büttner P, Weiss J, et al. Associated factors in the prevalence of more than 50 common melanocytic nevi, atypical melanocytic nevi, and actinic lentigines: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J Invest Dermatol 1994; 102:700.</a></li><li><a class="nounderline abstract_t">Schaffer JV. Update on melanocytic nevi in children. Clin Dermatol 2015; 33:368.</a></li><li><a class="nounderline abstract_t">Dellavalle RP, Johnson KR, Hester EJ, et al. Children with red hair have more freckles but fewer melanocytic nevi: results from a cohort study of 280 three-year-olds. Arch Dermatol 2005; 141:1042.</a></li><li><a class="nounderline abstract_t">Aalborg J, Morelli JG, Byers TE, et al. Effect of hair color and sun sensitivity on nevus counts in white children in Colorado. J Am Acad Dermatol 2010; 63:430.</a></li><li><a class="nounderline abstract_t">Koseoglu G, Akay BN, Kucuksahin O, Erdem C. Dermoscopic changes in melanocytic nevi in patients receiving immunosuppressive and biologic treatments: results of a prospective case-control study. J Am Acad Dermatol 2015; 73:623.</a></li><li><a class="nounderline abstract_t">Perry BM, Nguyen A, Desmond BL, et al. Eruptive nevi associated with medications (ENAMs). J Am Acad Dermatol 2016; 75:1045.</a></li><li><a class="nounderline abstract_t">Scope A, Marchetti MA, Marghoob AA, et al. The study of nevi in children: Principles learned and implications for melanoma diagnosis. J Am Acad Dermatol 2016; 75:813.</a></li><li><a class="nounderline abstract_t">Harrison SL, Buettner PG, MacLennan R. Body-site distribution of melanocytic nevi in young Australian children. Arch Dermatol 1999; 135:47.</a></li><li><a class="nounderline abstract_t">De Giorgi V, Sestini S, Grazzini M, et al. Prevalence and distribution of melanocytic naevi on the scalp: a prospective study. Br J Dermatol 2010; 162:345.</a></li><li><a class="nounderline abstract_t">Fonseca M, Marchetti MA, Chung E, et al. Cross-sectional analysis of the dermoscopic patterns and structures of melanocytic naevi on the back and legs of adolescents. Br J Dermatol 2015; 173:1486.</a></li><li><a class="nounderline abstract_t">Bastian BC. The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia. Annu Rev Pathol 2014; 9:239.</a></li><li><a class="nounderline abstract_t">Stark MS, Tan JM, Tom L, et al. Whole-Exome Sequencing of Acquired Nevi Identifies Mechanisms for Development and Maintenance of Benign Neoplasms. J Invest Dermatol 2018; 138:1636.</a></li><li><a class="nounderline abstract_t">Maher NG, Scolyer RA, Colebatch AJ. Biology and genetics of acquired and congenital melanocytic naevi. Pathology 2023; 55:169.</a></li><li><a class="nounderline abstract_t">Yeh I, von Deimling A, Bastian BC. Clonal BRAF mutations in melanocytic nevi and initiating role of BRAF in melanocytic neoplasia. J Natl Cancer Inst 2013; 105:917.</a></li><li><a class="nounderline abstract_t">Marchetti MA, Kiuru MH, Busam KJ, et al. Melanocytic naevi with globular and reticular dermoscopic patterns display distinct BRAF V600E expression profiles and histopathological patterns. Br J Dermatol 2014; 171:1060.</a></li><li><a class="nounderline abstract_t">Tang J, Fewings E, Chang D, et al. The genomic landscapes of individual melanocytes from human skin. Nature 2020; 586:600.</a></li><li><a class="nounderline abstract_t">Colebatch AJ, Ferguson P, Newell F, et al. Molecular Genomic Profiling of Melanocytic Nevi. J Invest Dermatol 2019; 139:1762.</a></li><li><a class="nounderline abstract_t">Siskind V, Darlington S, Green L, Green A. Evolution of melanocytic nevi on the faces and necks of adolescents: a 4 y longitudinal study. J Invest Dermatol 2002; 118:500.</a></li><li><a class="nounderline abstract_t">Reiter O, Kurtansky NR, Musthaq ST, et al. The long-term evolution of melanocytic nevi among high-risk adults. J Eur Acad Dermatol Venereol 2022; 36:2379.</a></li><li><a class="nounderline abstract_t">Scope A, Dusza SW, Marghoob AA, et al. Clinical and dermoscopic stability and volatility of melanocytic nevi in a population-based cohort of children in Framingham school system. J Invest Dermatol 2011; 131:1615.</a></li><li><a class="nounderline abstract_t">Bauer J, Garbe C. Acquired melanocytic nevi as risk factor for melanoma development. A comprehensive review of epidemiological data. Pigment Cell Res 2003; 16:297.</a></li><li><a class="nounderline abstract_t">Zalaudek I, Schmid K, Niederkorn A, et al. Proposal for a clinical-dermoscopic classification of scalp naevi. Br J Dermatol 2014; 170:1065.</a></li><li><a class="nounderline abstract_t">Kessides MC, Puttgen KB, Cohen BA. No biopsy needed for eclipse and cockade nevi found on the scalps of children. Arch Dermatol 2009; 145:1334.</a></li><li><a class="nounderline abstract_t">Coleman WP 3rd, Gately LE 3rd, Krementz AB, et al. Nevi, lentigines, and melanomas in blacks. Arch Dermatol 1980; 116:548.</a></li><li><a class="nounderline abstract_t">Martín RF, Sánchez JL, Vázquez-Botet M, Lugo A. Pigmented macules on palms and soles in Puerto Ricans. Int J Dermatol 1994; 33:418.</a></li><li><a class="nounderline abstract_t">Kogushi-Nishi H, Kawasaki J, Kageshita T, et al. The prevalence of melanocytic nevi on the soles in the Japanese population. J Am Acad Dermatol 2009; 60:767.</a></li><li><a class="nounderline abstract_t">Palicka GA, Rhodes AR. Acral melanocytic nevi: prevalence and distribution of gross morphologic features in white and black adults. Arch Dermatol 2010; 146:1085.</a></li><li><a class="nounderline abstract_t">Goettmann-Bonvallot S, André J, Belaich S. Longitudinal melanonychia in children: a clinical and histopathologic study of 40 cases. J Am Acad Dermatol 1999; 41:17.</a></li><li><a class="nounderline abstract_t">Buka R, Friedman KA, Phelps RG, et al. Childhood longitudinal melanonychia: case reports and review of the literature. Mt Sinai J Med 2001; 68:331.</a></li><li><a class="nounderline abstract_t">Drozdowski R, Spaccarelli N, Peters MS, Grant-Kels JM. Dysplastic nevus part I: Historical perspective, classification, and epidemiology. J Am Acad Dermatol 2023; 88:1.</a></li><li class="breakAll">WHO Classification of Skin Tumours, 4th Edition, Elder DE, Massi D, Scolyer RA, Willemze R (Eds), 2018.</li><li><a class="nounderline abstract_t">Zeff RA, Freitag A, Grin CM, Grant-Kels JM. The immune response in halo nevi. J Am Acad Dermatol 1997; 37:620.</a></li><li><a class="nounderline abstract_t">Kopf AW, Morrill SD, Silberberg I. Broad spectrum of leukoderma acquisitum centrifugum. Arch Dermatol 1965; 92:14.</a></li><li><a class="nounderline abstract_t">Mooney MA, Barr RJ, Buxton MG. Halo nevus or halo phenomenon? A study of 142 cases. J Cutan Pathol 1995; 22:342.</a></li><li><a class="nounderline abstract_t">Kolm I, Di Stefani A, Hofmann-Wellenhof R, et al. Dermoscopy patterns of halo nevi. Arch Dermatol 2006; 142:1627.</a></li><li><a class="nounderline abstract_t">Aouthmany M, Weinstein M, Zirwas MJ, Brodell RT. The natural history of halo nevi: a retrospective case series. J Am Acad Dermatol 2012; 67:582.</a></li><li><a class="nounderline abstract_t">Huynh PM, Lazova R, Bolognia JL. Unusual halo nevi--darkening rather than lightening of the central nevus. Dermatology 2001; 202:324.</a></li><li><a class="nounderline abstract_t">Patrizi A, Neri I, Sabattini E, et al. Unusual inflammatory and hyperkeratotic halo naevus in children. Br J Dermatol 2005; 152:357.</a></li><li><a class="nounderline abstract_t">Petkovic M, Susic SM, Toncic RJ. An Unusual Presentation of Halo Nevus in a Child. Dermatol Pract Concept 2019; 9:304.</a></li><li><a class="nounderline abstract_t">Haynes D, Strunck JL, Said J, et al. Association between halo nevi and melanoma in adults: A multicenter retrospective case series. J Am Acad Dermatol 2021; 84:1164.</a></li><li><a class="nounderline abstract_t">Lai C, Lockhart S, Mallory SB. Typical halo nevi in childhood: is a biopsy necessary? J Pediatr 2001; 138:283.</a></li><li><a class="nounderline abstract_t">González-Cámpora R, Galera-Davidson H, Vázquez-Ramírez FJ, Díaz-Cano S. Blue nevus: classical types and new related entities. A differential diagnostic review. Pathol Res Pract 1994; 190:627.</a></li><li><a class="nounderline abstract_t">Carney JA, Gordon H, Carpenter PC, et al. The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine (Baltimore) 1985; 64:270.</a></li><li><a class="nounderline abstract_t">Van Raamsdonk CD, Bezrookove V, Green G, et al. Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature 2009; 457:599.</a></li><li><a class="nounderline abstract_t">Emley A, Nguyen LP, Yang S, Mahalingam M. Somatic mutations in GNAQ in amelanotic/hypomelanotic blue nevi. Hum Pathol 2011; 42:136.</a></li><li><a class="nounderline abstract_t">Möller I, Murali R, Müller H, et al. Activating cysteinyl leukotriene receptor 2 (CYSLTR2) mutations in blue nevi. Mod Pathol 2017; 30:350.</a></li><li><a class="nounderline abstract_t">de la Fouchardiere A. Blue naevi and the blue tumour spectrum. Pathology 2023; 55:187.</a></li><li><a class="nounderline abstract_t">Matsuoka K, Tanaka R, Nomura T. Pencil-core granuloma. CMAJ 2022; 194:E14.</a></li><li><a class="nounderline abstract_t">Bittencourt MJS, Santos JEBD, Barros JNDS Junior, Xerfan EMS. Pencil-core granuloma. An Bras Dermatol 2017; 92:578.</a></li><li><a class="nounderline abstract_t">Sharma A. Graphite Foreign Body Misdiagnosed as a Blue Naevus-Like Localised Argyria. Clin Cosmet Investig Dermatol 2021; 14:1253.</a></li><li><a class="nounderline abstract_t">Granter SR, McKee PH, Calonje E, et al. Melanoma associated with blue nevus and melanoma mimicking cellular blue nevus: a clinicopathologic study of 10 cases on the spectrum of so-called 'malignant blue nevus'. Am J Surg Pathol 2001; 25:316.</a></li><li><a class="nounderline abstract_t">Aloi F, Pich A, Pippione M. Malignant cellular blue nevus: a clinicopathological study of 6 cases. Dermatology 1996; 192:36.</a></li><li><a class="nounderline abstract_t">Requena C, Traves V, Ferrandis E, et al. Melanoma arising in plaque-type blue nevus and dermal melanocytosis: Diagnostic and prognostic value of BAP1. Actas Dermosifiliogr 2023; 114:636.</a></li><li><a class="nounderline abstract_t">Sau P, Graham JH, Helwig EB. Pigmented spindle cell nevus: a clinicopathologic analysis of ninety-five cases. J Am Acad Dermatol 1993; 28:565.</a></li><li><a class="nounderline abstract_t">Wiesner T, He J, Yelensky R, et al. Kinase fusions are frequent in Spitz tumours and spitzoid melanomas. Nat Commun 2014; 5:3116.</a></li></ol></div><div id="topicVersionRevision">Topic 4846 Version 21.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35446494" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : The spectrum of melanocytic nevi and their clinical implications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25307738" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Genetic factors associated with naevus count and dermoscopic patterns: preliminary results from the Study of Nevi in Children (SONIC).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36342513" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Overview of familial syndromes with increased skin malignancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12507670" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Sun exposure and number of nevi in 5- to 6-year-old European children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12548604" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Moderate sun exposure and nevus counts in parents are associated with development of melanocytic nevi in childhood: a risk factor study in 1,812 kindergarten children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18768500" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Sun exposure and the incidence of melanocytic nevi in young Australian children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19001133" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Study of Nevi in Children (SONIC): baseline findings and predictors of nevus count.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19770437" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Tanning and increased nevus development in very-light-skinned children without red hair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29614272" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Sun-Protection Behavior, Pubertal Development and Menarche: Factors Influencing the Melanocytic Nevi Development-The Results of an Observational Study of 1,512 Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30208471" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Trajectories of Nevus Development From Age 3 to 16 Years in the Colorado Kids Sun Care Program Cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10865273" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Broad-spectrum sunscreen use and the development of new nevi in white children: A randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9862624" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Sunscreen use, wearing clothes, and number of nevi in 6- to 7-year-old European children. European Organization for Research and Treatment of Cancer Melanoma Cooperative Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17630608" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Pigmented lesions in children: when to worry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8961877" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Increase of melanocytic nevus counts in children during 5 years of follow-up and analysis of associated factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8176251" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Associated factors in the prevalence of more than 50 common melanocytic nevi, atypical melanocytic nevi, and actinic lentigines: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25889140" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Update on melanocytic nevi in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16103341" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Children with red hair have more freckles but fewer melanocytic nevi: results from a cohort study of 280 three-year-olds.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20584558" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Effect of hair color and sun sensitivity on nevus counts in white children in Colorado.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26293825" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Dermoscopic changes in melanocytic nevi in patients receiving immunosuppressive and biologic treatments: results of a prospective case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27241804" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Eruptive nevi associated with medications (ENAMs).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27320410" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : The study of nevi in children: Principles learned and implications for melanoma diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9923780" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Body-site distribution of melanocytic nevi in young Australian children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19886886" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Prevalence and distribution of melanocytic naevi on the scalp: a prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26189624" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Cross-sectional analysis of the dermoscopic patterns and structures of melanocytic naevi on the back and legs of adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24460190" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29476775" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Whole-Exome Sequencing of Acquired Nevi Identifies Mechanisms for Development and Maintenance of Benign Neoplasms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36635156" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Biology and genetics of acquired and congenital melanocytic naevi.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23690527" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Clonal BRAF mutations in melanocytic nevi and initiating role of BRAF in melanocytic neoplasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25039578" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Melanocytic naevi with globular and reticular dermoscopic patterns display distinct BRAF V600E expression profiles and histopathological patterns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33029006" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : The genomic landscapes of individual melanocytes from human skin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30772300" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Molecular Genomic Profiling of Melanocytic Nevi.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11874490" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Evolution of melanocytic nevi on the faces and necks of adolescents: a 4 y longitudinal study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35881111" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : The long-term evolution of melanocytic nevi among high-risk adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21562569" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Clinical and dermoscopic stability and volatility of melanocytic nevi in a population-based cohort of children in Framingham school system.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12753404" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Acquired melanocytic nevi as risk factor for melanoma development. A comprehensive review of epidemiological data.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24641327" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Proposal for a clinical-dermoscopic classification of scalp naevi.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19917973" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : No biopsy needed for eclipse and cockade nevi found on the scalps of children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7377786" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Nevi, lentigines, and melanomas in blacks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8056475" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Pigmented macules on palms and soles in Puerto Ricans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19389519" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : The prevalence of melanocytic nevi on the soles in the Japanese population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20956637" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Acral melanocytic nevi: prevalence and distribution of gross morphologic features in white and black adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10411404" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Longitudinal melanonychia in children: a clinical and histopathologic study of 40 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11514921" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Childhood longitudinal melanonychia: case reports and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36038073" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Dysplastic nevus part I: Historical perspective, classification, and epidemiology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36038073" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Dysplastic nevus part I: Historical perspective, classification, and epidemiology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9344203" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : The immune response in halo nevi.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11850948" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Broad spectrum of leukoderma acquisitum centrifugum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7499574" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Halo nevus or halo phenomenon? A study of 142 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17178990" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Dermoscopy patterns of halo nevi.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22387032" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : The natural history of halo nevi: a retrospective case series.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11455145" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Unusual halo nevi--darkening rather than lightening of the central nevus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15727653" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Unusual inflammatory and hyperkeratotic halo naevus in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31723468" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : An Unusual Presentation of Halo Nevus in a Child.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32822787" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Association between halo nevi and melanoma in adults: A multicenter retrospective case series.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11174633" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Typical halo nevi in childhood: is a biopsy necessary?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7984522" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Blue nevus: classical types and new related entities. A differential diagnostic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4010501" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : The complex of myxomas, spotty pigmentation, and endocrine overactivity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19078957" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21056896" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Somatic mutations in GNAQ in amelanotic/hypomelanotic blue nevi.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27934878" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Activating cysteinyl leukotriene receptor 2 (CYSLTR2) mutations in blue nevi.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36641378" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Blue naevi and the blue tumour spectrum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35012948" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Pencil-core granuloma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28954120" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Pencil-core granuloma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34557010" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Graphite Foreign Body Misdiagnosed as a Blue Naevus-Like Localised Argyria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11224601" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Melanoma associated with blue nevus and melanoma mimicking cellular blue nevus: a clinicopathologic study of 10 cases on the spectrum of so-called 'malignant blue nevus'.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8832950" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Malignant cellular blue nevus: a clinicopathological study of 6 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37088284" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Melanoma arising in plaque-type blue nevus and dermal melanocytosis: Diagnostic and prognostic value of BAP1.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8463457" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Pigmented spindle cell nevus: a clinicopathologic analysis of ninety-five cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24445538" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Kinase fusions are frequent in Spitz tumours and spitzoid melanomas.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
